CVS Health will no longer offer the Johnson & Johnson COVID-19 vaccine at pharmacy locations.
The national chain draws single-dose vaccines from most of its locations, but CNBC reports that it still offers double-dose Pfizer-BioNTech and Moderna vaccines.
CVS Minute Clinics, a small facility in some locations, occupies only 10% of the company’s location, but continues to offer J & J shots.
This is yet another setback for New Jersey-based companies that have been in trouble since the vaccine was first approved in February.
CVS will stop carrying the Johnson & Johnson vaccine at the pharmacy location after months of single-dose jab confusion.Photo: Location of CVS Pharmacy in Mount Lebanon, Pennsylvania
CVS Health did not provide the reason behind CNBC’s outage.
However, the chain says it has run out of all J & J vaccines and pharmacies and has not ordered any more doses.
However, CVS spokesman Mike DeAngelis said the vaccine will also be available at the company’s 1,000 Minute Clinic location, which provides non-emergency services in 25 states and the District of Columbia.
Confidence in the only one-shot vaccine available in the United States has diminished over the past few months.
Only weeks after approval, vaccine use was suspended by the US Food and Drug Administration (FDA) and the US Centers for Disease Control and Prevention (CDC) after some recipients formed blood clots.
The pause was lifted after 11 days, but a new blood clot warning was added to the label.
Also, in April, the Baltimore plant that produced the shots had to be closed, and 75 million doses had to be discarded after some vials of the vaccine were contaminated with AstraZeneca vaccine components, according to a study. An unsanitary condition has been revealed.
After that, the Baltimore factory was reopened.
Detroit mayor Mike Duggan said the Pfizer and Modana versions were better, and even refused to give the city the first J & J vaccine in March.
“So Johnson & Johnson is a very good vaccine. Moderna and Pfizer are great. And I will do everything I can to ensure that the Detroit residents do their best,” Dagan said. Said.
Last month, the FDA revised the vaccine label and added a warning that the shot was associated with Guillain-Barré syndrome. Guillain-Barré syndrome is a rare autoimmune disease in which the human immune system attacks one’s nerves.
Earlier this week in San Francisco, the city began offering “supplementary” shots of the Moderna or Pfizer vaccine to those who had previously received the J & J vaccine, upon request.
The Johnson & Johnson vaccine has faced a setback since it was first approved. Within just a few weeks, approval was suspended due to blood clotting problems.Photo: Johnson & Johnson Vaccine Vial
The Johnson & Johnson vaccine has been used 13.5 million times in the United States. This is inferior to the use of Moderna and Pfizer vaccines.
“We continue to work to end this deadly pandemic as quickly as possible,” Johnson & Johnson said in a statement, according to CNBC.
“A single vaccine that provides protection and prevents hospitalization and death is an important tool in the global battle against COVID-19.
Evidence from the’Phase 3 ENSEMBLE study demonstrates the efficacy of the J & J single-shot COVID-19 vaccine, including against highly prevalent viral variants. These results are consistent regardless of race, ethnicity, age, geographic location, or comorbidities.
In early July, the company released data showing that the vaccine is effective in combating Indian “delta” mutants even eight months after receipt.
However, in a New York University study, researchers found that the vaccine was of little help in combating delta mutants.
According to official data from the Centers for Disease Control and Prevention, the vaccine has been administered 13.5 million times and has been dwarfed by the Pfizer vaccine (194 million doses) and Modana (139 million doses).
CVS says pharmacies have stopped offering the Johnson & Johnson Covid vaccine
Source link CVS says pharmacies have stopped offering the Johnson & Johnson Covid vaccine